Giovanni Vittimberga
Overview
Explore the profile of Giovanni Vittimberga including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
16
Citations
213
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Monti M, Prochowski Iamurri A, Bianchini D, Gallio C, Esposito L, Montanari D, et al.
Nutrients
. 2023 Aug;
15(16).
PMID: 37630794
Background And Aims: Perioperative treatment is currently the gold standard approach in Europe for locally advanced gastric cancer (GC). Unfortunately, the phenomenon of patients dropping out of treatment has been...
2.
Salati M, De Ruvo N, Giglio M, Sorrentino L, Esposito G, Fenocchi S, et al.
J Clin Med
. 2022 Sep;
11(18).
PMID: 36143086
Background. More than 50% of operable GEA relapse after curative-intent resection. We aimed at externally validating a nomogram to enable a more accurate estimate of individualized risk in resected GEA....
3.
Baiocchi G, Giacopuzzi S, Vittimberga G, De Pascale S, Pastorelli E, Gelmini R, et al.
Updates Surg
. 2022 Jul;
75(2):419-427.
PMID: 35788552
Gastrectomy for gastric cancer is still performed in Western countries with high morbidity and mortality. Post-operative complications are frequent, and effective diagnosis and treatment of complications is crucial to lower...
4.
Morgagni P, Solaini L, Saragoni L, Monti M, Valgiusti M, Vittimberga G, et al.
Front Oncol
. 2022 Mar;
12:852559.
PMID: 35356199
Background: After the REGATTA trial, patients with stage IV gastric cancer could only benefit from chemotherapy (CHT). However, some of these patients may respond extraordinarily to palliative chemotherapy, converting their...
5.
Morgagni P, La Barba G, Colciago E, Vittimberga G, Ercolani G
Updates Surg
. 2018 Jun;
70(2):213-223.
PMID: 29934732
The optimal management of patients with resection line involvement after endoscopic or surgical treatment for gastric cancer is debated. In contrast to previous reports, we examined both the experience of...
6.
Morgagni P, Solaini L, Framarini M, Vittimberga G, Gardini A, Tringali D, et al.
Int J Surg
. 2018 Apr;
53:360-365.
PMID: 29654967
Background: Advanced unresectable gastric cancer has a dismal prognosis. The aim of this study was to evaluate the short- and long-term outcomes of patients who underwent induction chemotherapy ± gastrectomy...
7.
Morgagni P, Solaini L, Saragoni L, Bencivenga M, Romario U, Graziosi L, et al.
Eur J Surg Oncol
. 2018 Apr;
44(8):1186-1190.
PMID: 29628438
Background: To investigate the role of Kodama PenA subtype in influencing survival in patients with early gastric cancer (EGC). Methods: All patients surgically treated for EGC at 7 Italian centers...
8.
Morgagni P, Tringali D, La Barba G, Vittimberga G, Ercolani G
Transl Gastroenterol Hepatol
. 2017 Feb;
1:90.
PMID: 28138655
The role of lymphadenectomy for the treatment of gastric cancer is still very much open to debate. Consequently, Japanese, European and American surgeons perform different typologies of lymphadenectomy because of...
9.
Rosa F, Marrelli D, Morgagni P, Cipollari C, Vittimberga G, Framarini M, et al.
World J Surg
. 2015 Nov;
40(4):921-8.
PMID: 26552908
Background: In case of Krukenberg tumor (KT) of gastric origin it is controversial and debated whether radical surgery in case of synchronous KT or metastasectomy in case of metachronous ones...
10.
Morgagni P, Gardini A, Marrelli D, Vittimberga G, Marchet A, De Manzoni G, et al.
Am J Surg
. 2014 Sep;
209(6):1063-8.
PMID: 25218580
Background: Gastric stump carcinoma (GSC) has been studied after primary gastrectomy for benign disease but few studies have evaluated its correlation with gastric cancer. Patients: We assessed 541 patients submitted...